Your browser doesn't support javascript.
'Immunity Passports' for SARS-CoV-2: an online experimental study of the impact of antibody test terminology on perceived risk and behaviour.
Waller, Jo; Rubin, G James; Potts, Henry W W; Mottershaw, Abigail L; Marteau, Theresa M.
  • Waller J; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Rubin GJ; Department of Psychological Medicine, King's College London, London, UK.
  • Potts HWW; Centre for Health Informatics and Multiprofessional Education, UCL, London, UK.
  • Mottershaw AL; Behavioural Insights Team, London, UK.
  • Marteau TM; Behaviour and Health Research Unit, University of Cambridge, Cambridge, UK tm388@cam.ac.uk.
BMJ Open ; 10(8): e040448, 2020 08 30.
Artículo en Inglés | MEDLINE | ID: covidwho-739117
Preprint
Este artículo de revista científica es probablemente basado en un preprint previamente disponible, por medio del reconocimiento de similitud realizado por una máquina. La confirmación humana aún está pendiente.
Ver preprint
ABSTRACT

OBJECTIVE:

To assess the impact of describing an antibody-positive test result using the terms Immunity and Passport or Certificate, alone or in combination, on perceived risk of becoming infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and protective behaviours.

DESIGN:

2×3 experimental design.

SETTING:

Online.

PARTICIPANTS:

1204 adults from a UK research panel. INTERVENTION Participants were randomised to receive one of six descriptions of an antibody test and results showing SARS-CoV-2 antibodies, differing in the terms describing the type of test (Immunity vs Antibody) and the test result (Passport vs Certificate vs Test). MAIN OUTCOME

MEASURES:

Primary

outcome:

proportion of participants perceiving no risk of infection with SARS-CoV-2 given an antibody-positive test result. Other outcomes include intended changes to frequency of hand washing and physical distancing.

RESULTS:

When using the term Immunity (vs Antibody), 19.1% of participants (95% CI 16.1% to 22.5%) (vs 9.8% (95% CI 7.5% to 12.4%)) perceived no risk of catching coronavirus given an antibody-positive test result (adjusted OR (AOR) 2.91 (95% CI 1.52 to 5.55)). Using the terms Passport or Certificate-as opposed to Test-had no significant effect (AOR 1.24 (95% CI 0.62 to 2.48) and AOR 0.96 (95% CI 0.47 to 1.99) respectively). There was no significant interaction between the effects of the test and result terminology. Across groups, perceiving no risk of infection was associated with an intention to wash hands less frequently (AOR 2.32 (95% CI 1.25 to 4.28)); there was no significant association with intended avoidance of physical contact (AOR 1.37 (95% CI 0.93 to 2.03)).

CONCLUSIONS:

Using the term Immunity (vs Antibody) to describe antibody tests for SARS-CoV-2 increases the proportion of people believing that an antibody-positive result means they have no risk of catching coronavirus in the future, a perception that may be associated with less frequent hand washing. TRIAL REGISTRATION NUMBER Open Science Framework https//osf.io/tjwz8/files/.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Neumonía Viral / Conductas Relacionadas con la Salud / Conocimientos, Actitudes y Práctica en Salud / Infecciones por Coronavirus / Comunicación / Pandemias / Inmunidad / Anticuerpos Antivirales Tipo de estudio: Estudio experimental / Estudio pronóstico / Ensayo controlado aleatorizado Límite: Adulto / Femenino / Humanos / Masculino País/Región como asunto: Europa Idioma: Inglés Revista: BMJ Open Año: 2020 Tipo del documento: Artículo País de afiliación: Bmjopen-2020-040448

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Neumonía Viral / Conductas Relacionadas con la Salud / Conocimientos, Actitudes y Práctica en Salud / Infecciones por Coronavirus / Comunicación / Pandemias / Inmunidad / Anticuerpos Antivirales Tipo de estudio: Estudio experimental / Estudio pronóstico / Ensayo controlado aleatorizado Límite: Adulto / Femenino / Humanos / Masculino País/Región como asunto: Europa Idioma: Inglés Revista: BMJ Open Año: 2020 Tipo del documento: Artículo País de afiliación: Bmjopen-2020-040448